Wegovy

Healthcare

Novo Nordisk’s Doing Brilliantly, Just Not Brilliantly Enough

Photo via Novo Nordisk

Novo Nordisk reported earnings, posting some chunky year-over-year growth and far outperforming its only real rival at the moment, Eli Lilly.

1 min read

Photo by Jetcityimage via iStock

Healthcare

Eli Lilly’s Weight-Loss Drug Finally Off FDA Shortage List

The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.

1 min read
Photo by Chemist4U via CC BY-SA 2.0

Healthcare

Making Weight-Loss Drugs Takes a Whole Lot of Muscle

In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.

1 min read
Photo by News Øresund – Johan Wessman via CC BY 2.0

Markets

Novo Nordisk Slips Amid Disappointing Wegovy Sales

Novo Nordisk’s share price fell over 8% on Wednesday after the company reported lower-than-expected sales of Wegovy.

2 min read

Photo by Kārlis Dambrāns via CC BY-SA 4.0

International Economics

China Brings in Subsidies for Smartphones

On Friday, Beijing announced that a trade-in program that previously applied to big appliances and cars will now be widened to smartphones.

1 min read
Photo by David Vives via Unsplash

Private Equity

Will Private Equity Fuel a Big Year for IPOs?

As the New Year rolls in, Wall Street is preparing for a slew of listing announcements from private equity-backed firms.

2 min read
Photo illustration by Connor Lin / The Daily Upside, Photo by Rawpixel via Freepik

Private Equity

All in the Franchise: Why Private Equity Loves the Business Model

It’s understandable if you failed to notice one meaty if unglamorous trend on Wall Street: Private equity’s love affair with franchising.

6 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.